A global functional network biomarker across aging and dysexecutive Alzheimer’s disease
Nick Corriveau‐Lecavalier(Mayo Clinic), David T. Jones(Alzheimer’s Disease Neuroimaging Initiative), Essa Yacoub(University of Minnesota), Daniela A. Wiepert(Mayo Clinic), Ronald C. Petersen(Mayo Clinic in Arizona), Hugo Botha(Mayo Clinic), Kǎmil Uǧurbil(Resonance Research (United States)), Melissa Terpstra(University of Minnesota), David S. Knopman(Mayo Clinic), Christopher G. Schwarz(Mayo Clinic in Arizona), Bradley F. Boeve(Mayo Clinic in Arizona), Michael G. Kamykowski(Mayo Clinic), Clifford R. Jack(Mayo Clinic), Jonathan Graff Radford(Mayo Clinic), Jeffrey L. Gunter(Mayo Clinic in Arizona)
Cited by 1
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k